Correlation Between Eguana Technologies and VentriPoint Diagnostics

Can any of the company-specific risk be diversified away by investing in both Eguana Technologies and VentriPoint Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eguana Technologies and VentriPoint Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eguana Technologies and VentriPoint Diagnostics, you can compare the effects of market volatilities on Eguana Technologies and VentriPoint Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eguana Technologies with a short position of VentriPoint Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eguana Technologies and VentriPoint Diagnostics.

Diversification Opportunities for Eguana Technologies and VentriPoint Diagnostics

-0.36

Correlation Coefficient

Eguana Technologies  VentriPoint Diagnostics

Very good diversification

The 3 months correlation between Eguana and VentriPoint is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Eguana Technologies and VentriPoint Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VentriPoint Diagnostics and Eguana Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eguana Technologies are associated (or correlated) with VentriPoint Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VentriPoint Diagnostics has no effect on the direction of Eguana Technologies i.e., Eguana Technologies and VentriPoint Diagnostics go up and down completely randomly.

Pair Corralation between Eguana Technologies and VentriPoint Diagnostics

Assuming the 90 days horizon Eguana Technologies is expected to generate 2.26 times more return on investment than VentriPoint Diagnostics. However, Eguana Technologies is 2.26 times more volatile than VentriPoint Diagnostics. It trades about 0.06 of its potential returns per unit of risk. VentriPoint Diagnostics is currently generating about -0.14 per unit of risk. If you would invest  1.00  in Eguana Technologies on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Eguana Technologies or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Eguana Technologies  vs.  VentriPoint Diagnostics

Eguana Technologies

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eguana Technologies are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Eguana Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

VentriPoint Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Eguana Technologies and VentriPoint Diagnostics

The main advantage of trading using opposite Eguana Technologies and VentriPoint Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eguana Technologies position performs unexpectedly, VentriPoint Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VentriPoint Diagnostics will offset losses from the drop in VentriPoint Diagnostics' long position.

The idea behind Eguana Technologies and VentriPoint Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.